SCHEMBL4725776

SCHEMBL4725776

CC(C)C[C@@H]([C]=O)NC(=O)N1CCN(Cc2ccccc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
FAAH O00519 9/20 0.54
KDM4E B2RXH2 2/20 0.52
MAPT P10636 1/20 0.52
ALDH1A1 P00352 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CA12 O43570 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
PKM P14618 1/20 0.49
HTT P42858 1/20 0.49
CTSS P25774 1/20 0.48
MAPK1 P28482 2/20 0.48
GAA P10253 1/20 0.48
USP2 O75604 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6201382 0.79 CTSS (0.62) CYP3A4CYP2D6CYP2C9CYP2C19FAAH
SCHEMBL7342680 0.78 CYP3A4 (0.61) CYP3A4CYP2D6CYP2C9CYP2C19FAAH
SCHEMBL7342675 0.78 CYP3A4 (0.61) CYP3A4CYP2D6CYP2C9CYP2C19FAAH
SCHEMBL10858751 0.76 ALDH1A1 (0.59) CYP3A4CYP2D6CYP2C9CYP2C19FAAH
SCHEMBL10858747 0.76 ALDH1A1 (0.59) CYP3A4CYP2D6CYP2C9CYP2C19FAAH
SCHEMBL4725802 0.75 POLB (0.61) FAAHMEN1KMT2ACTSS
SCHEMBL3968410 0.75 MMP1 (0.42) CYP2C9ALDH1A1SMN1; SMN2PKMCTSS
SCHEMBL1821860 0.75 FAAH (0.70) CYP3A4CYP2D6CYP2C9CYP2C19FAAH
SCHEMBL7440380 0.75 CYP2D6 (0.71) CYP3A4CYP2D6CYP2C9CYP2C19FAAH
SCHEMBL7440377 0.75 CYP2D6 (0.71) CYP3A4CYP2D6CYP2C9CYP2C19FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021210-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS COMBINATORX, INCORPORATED (US) 2008-02-21 WO disclosed